icotec ag, an Altsteatten, Switzerland-based company advancing innovative spinal tumor implants, raised $30M in Growth funding.
MVM Partners made the investment. WISTAMA Finanz- und Beteiligungs AG, the family office of the Stadler family that founded the company, remains fully invested as majority shareholder and committed to the long-term development of icotec.
The company intends to use the funds to continue its growth and strengthen its research and development capabilities to expand the portfolio into the underserved indications of spinal infection and osteoporosis.
Led by CEO Roger Stadler, icotec is treating spinal tumors with a new generation of high-tech implants. With its BlackArmor® Carbon/PEEK implants, the company combines technologies and industry expertise to deliver innovative solutions for spine surgeons and their patients and is dedicated to advancing the field of spinal implantation. Since receiving FDA clearance in 2019, many designated US cancer centers have adopted the BlackArmor® products.
FinSMEs
24/01/2024